LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Effects of the presence of fibrin strands on complete blood count parameters.

    Rosetti, Marco / Olivieri, Melania / Polli, Valentina / Massari, Evita / Monti, Marta / Clementoni, Alice / Libri, Virginia / Poletti, Giovanni / Fasano, Tommaso

    Scandinavian journal of clinical and laboratory investigation

    2024  Volume 83, Issue 8, Page(s) 620–621

    MeSH term(s) Humans ; Fibrin ; Blood Cell Count
    Chemical Substances Fibrin (9001-31-4)
    Language English
    Publishing date 2024-01-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 3150-1
    ISSN 1502-7686 ; 0036-5513
    ISSN (online) 1502-7686
    ISSN 0036-5513
    DOI 10.1080/00365513.2023.2292601
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Unexpected detection of various pathological features due to the careful evaluation of Cellavision (DI-60) software.

    Rosetti, Marco / Di Carlo, Claudia / Poletti, Giovanni / Massari, Evita / Monti, Marta / Romano, Giuseppe / Libri, Virginia / Olivieri, Melania / Polli, Valentina / Baldrati, Luca / Valenti, Stefania / Fasano, Tommaso

    Journal of clinical pathology

    2022  Volume 76, Issue 2, Page(s) 141–142

    MeSH term(s) Humans ; Microscopy ; Software ; Telepathology
    Language English
    Publishing date 2022-08-23
    Publishing country England
    Document type Letter
    ZDB-ID 80261-x
    ISSN 1472-4146 ; 0021-9746
    ISSN (online) 1472-4146
    ISSN 0021-9746
    DOI 10.1136/jcp-2022-208489
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Parasitised red blood cells misclassified as giant platelets by an automated digital morphology analyser (Sysmex DI-60/CellaVision): a case report and a retrospective EQA analysis.

    Rosetti, Marco / Farneti, Giorgia / Monti, Marta / Torri, Arianna / Poletti, Giovanni / Massari, Evita / Polli, Valentina / Clementoni, Alice / Dorizzi, Romolo M

    British journal of haematology

    2020  Volume 192, Issue 3, Page(s) e90–e92

    MeSH term(s) Adult ; Blood Platelets/cytology ; Blood Platelets/ultrastructure ; Cell Size ; Diagnosis, Computer-Assisted ; Diagnostic Errors ; Erythrocytes/parasitology ; Erythrocytes/ultrastructure ; Humans ; Malaria/diagnosis ; Male ; Microscopy ; Plasmodium/isolation & purification ; Retrospective Studies ; Software
    Language English
    Publishing date 2020-12-18
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.17276
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions.

    Tosi, Patrizia / Tomassetti, Simona / Merli, Anna / Polli, Valentina

    Therapeutic advances in hematology

    2013  Volume 4, Issue 1, Page(s) 37–41

    Abstract: Diagnosis and monitoring of multiple myeloma (MM) and related conditions are usually carried out by means of serum and urine protein electrophoresis and immunofixation. In the early 2000s, an assay aimed at evaluating serum free light chains (sFLCs) was ... ...

    Abstract Diagnosis and monitoring of multiple myeloma (MM) and related conditions are usually carried out by means of serum and urine protein electrophoresis and immunofixation. In the early 2000s, an assay aimed at evaluating serum free light chains (sFLCs) was made available and subsequently tested in different plasma cell disorders. Several reports have demonstrated the usefulness of the assay for the diagnosis and monitoring of oligosecretory MM, nonsecretory MM, Bence Jones MM, and amyloid light-chain amyloidosis. Furthermore, a prognostic role for an abnormal sFLC κ/λ ratio has been observed in the case of monoclonal gammopathy of unknown significance, smoldering MM, solitary plasmacytomas, and in newly diagnosed symptomatic MM secreting intact monoclonal immunoglobulins. In conclusion, according to present data, the sFLC assay can be considered reliable for the diagnosis, monitoring, and prognosis of different plasma cell disorders, and recently studies have been carried out to test a possible role of an sFLC evaluation in other B-cell lymphoproliferative malignancies.
    Language English
    Publishing date 2013-04-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2585183-4
    ISSN 2040-6215 ; 2040-6207
    ISSN (online) 2040-6215
    ISSN 2040-6207
    DOI 10.1177/2040620712466863
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study.

    Visco, Carlo / Di Rocco, Alice / Evangelista, Andrea / Quaglia, Francesca Maria / Tisi, Maria Chiara / Morello, Lucia / Zilioli, Vittorio Ruggero / Rusconi, Chiara / Hohaus, Stefan / Sciarra, Roberta / Re, Alessandro / Tecchio, Cristina / Chiappella, Annalisa / Marin-Niebla, Ana / McCulloch, Rory / Gini, Guido / Perrone, Tommasina / Nassi, Luca / Pennese, Elsa /
    Stefani, Piero Maria / Cox, Maria Christina / Bozzoli, Valentina / Fabbri, Alberto / Polli, Valentina / Ferrero, Simone / De Celis, Maria Isabel Alvarez / Sica, Antonello / Petrucci, Luca / Arcaini, Luca / Rule, Simon / Krampera, Mauro / Vitolo, Umberto / Balzarotti, Monica

    Leukemia

    2021  Volume 35, Issue 3, Page(s) 932

    Language English
    Publishing date 2021-01-22
    Publishing country England
    Document type Published Erratum
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-020-01119-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study.

    Visco, Carlo / Di Rocco, Alice / Evangelista, Andrea / Quaglia, Francesca Maria / Tisi, Maria Chiara / Morello, Lucia / Zilioli, Vittorio Ruggero / Rusconi, Chiara / Hohaus, Stefan / Sciarra, Roberta / Re, Alessandro / Tecchio, Cristina / Chiappella, Annalisa / Marin-Niebla, Ana / McCulloch, Rory / Gini, Guido / Perrone, Tommasina / Nassi, Luca / Pennese, Elsa /
    Stefani, Piero Maria / Cox, Maria Christina / Bozzoli, Valentina / Fabbri, Alberto / Polli, Valentina / Ferrero, Simone / Celis, Maria Isabel Alvarez De / Sica, Antonello / Petrucci, Luca / Arcaini, Luca / Rule, Simon / Krampera, Mauro / Vitolo, Umberto / Balzarotti, Monica

    Leukemia

    2020  Volume 35, Issue 3, Page(s) 787–795

    Abstract: Patients with mantle cell lymphoma (MCL) that fail induction treatment represent a difficult-to-treat population, where no standard therapy exists. We evaluated outcomes in patients with first relapsed-refractory (r/r) MCL after upfront high dose ... ...

    Abstract Patients with mantle cell lymphoma (MCL) that fail induction treatment represent a difficult-to-treat population, where no standard therapy exists. We evaluated outcomes in patients with first relapsed-refractory (r/r) MCL after upfront high dose cytarabine including standard regimens. Overall survival (OS-2) and progression-free survival (PFS-2) were estimated from the time of salvage therapy. The previously described threshold of 24 months was used to define patients as early- or late-progressors (POD). Overall, 261 r/r MCL patients were included. Second-line regimens consisted of rituximab-bendamustine (R-B, 21%), R-B and cytarabine (R-BAC, 29%), ibrutinib (19%), and others (31%). The four groups were balanced in terms of clinicopathological features. Adjusting for age and early/late-POD, patients treated with R-BAC had significantly higher complete remission (63%) than comparators. Overall, Ibrutinib and R-BAC were associated with improved median PFS-2 [24 and 25 months, respectively], compared to R-B (13) or others (7). In patients with early-POD (n = 127), ibrutinib was associated with inferior risk of death than comparators (HR 2.41 for R-B, 2.17 for others, 2.78 for R-BAC). In patients with late-POD (n = 134), no significant differences were observed between ibrutinib and bendamustine-based treatments. Ibrutinib was associated with improved outcome in early-POD patients.
    MeSH term(s) Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Drug Resistance, Neoplasm ; Female ; Follow-Up Studies ; Humans ; International Agencies ; Lymphoma, Mantle-Cell/drug therapy ; Lymphoma, Mantle-Cell/mortality ; Lymphoma, Mantle-Cell/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies ; Salvage Therapy ; Survival Rate ; Young Adult
    Language English
    Publishing date 2020-08-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-020-01013-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: In Ph+BCR-ABL1

    Baccarani, Michele / Iacobucci, Ilaria / Chiaretti, Sabina / Foà', Robin / Balasubramanian, Poonkuzhali / Paietta, Elisabeth / Foroni, Letizia / Jeromin, Sabine / Izzo, Barbara / Spinelli, Orietta / Varma, Neelam / Menif, Samia / Terragna, Carolina / Seth, Tulika / Bidet, Audrey / Coriu, Daniel / Lunghi, Francesca / Mayer, Jiri / Scappini, Barbara /
    Langabeer, Stephen / Maier, Jacqueline / Burt, Emma / Candoni, Anna / Albano, Francesco / Luppi, Mario / Zupan, Irena / Lion, Thomas / Zadro, Renata / di Raimondo, Francesco / Poopak, Behzad / Rege-Cambrin, Giovanna / Annunziata, Mario / Ayala, Ana / Salinas-Viedma, Victor / Ines Prado, Ana / Milner, Benedict / Galimberti, Sara / Janssen, Jeroen / Polli, Valentina / Comba, Lorenzo / Borsellino, Beatrice / Annibali, Ombretta / Crugnola, Monica / Passamonti, Francesco

    Leukemia

    2019  Volume 34, Issue 3, Page(s) 929–931

    MeSH term(s) Adolescent ; Adult ; Age Factors ; Aged ; B-Lymphocytes/immunology ; Child ; Female ; Fusion Proteins, bcr-abl/genetics ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Proto-Oncogene Proteins c-abl/immunology ; Young Adult
    Chemical Substances BCR-ABL1 fusion protein, human ; ABL1 protein, human (EC 2.7.10.2) ; Fusion Proteins, bcr-abl (EC 2.7.10.2) ; Proto-Oncogene Proteins c-abl (EC 2.7.10.2)
    Language English
    Publishing date 2019-10-08
    Publishing country England
    Document type Letter ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-019-0591-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top